Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HEU0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 151 | 155 | PF00656 | 0.521 |
CLV_C14_Caspase3-7 | 177 | 181 | PF00656 | 0.351 |
CLV_C14_Caspase3-7 | 77 | 81 | PF00656 | 0.587 |
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.357 |
CLV_NRD_NRD_1 | 195 | 197 | PF00675 | 0.428 |
CLV_NRD_NRD_1 | 318 | 320 | PF00675 | 0.397 |
CLV_NRD_NRD_1 | 87 | 89 | PF00675 | 0.472 |
CLV_PCSK_FUR_1 | 106 | 110 | PF00082 | 0.354 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.342 |
CLV_PCSK_KEX2_1 | 280 | 282 | PF00082 | 0.403 |
CLV_PCSK_KEX2_1 | 318 | 320 | PF00082 | 0.487 |
CLV_PCSK_PC1ET2_1 | 280 | 282 | PF00082 | 0.337 |
CLV_PCSK_SKI1_1 | 265 | 269 | PF00082 | 0.445 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.540 |
DEG_APCC_DBOX_1 | 69 | 77 | PF00400 | 0.564 |
DOC_MAPK_gen_1 | 196 | 203 | PF00069 | 0.338 |
DOC_MAPK_MEF2A_6 | 196 | 205 | PF00069 | 0.335 |
DOC_PP2B_LxvP_1 | 24 | 27 | PF13499 | 0.538 |
DOC_PP2B_LxvP_1 | 252 | 255 | PF13499 | 0.410 |
DOC_PP4_FxxP_1 | 208 | 211 | PF00568 | 0.359 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.506 |
DOC_USP7_MATH_1 | 133 | 137 | PF00917 | 0.710 |
DOC_USP7_MATH_1 | 257 | 261 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.517 |
DOC_USP7_MATH_1 | 289 | 293 | PF00917 | 0.458 |
DOC_WW_Pin1_4 | 207 | 212 | PF00397 | 0.297 |
DOC_WW_Pin1_4 | 250 | 255 | PF00397 | 0.423 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.416 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.469 |
LIG_BIR_III_4 | 149 | 153 | PF00653 | 0.525 |
LIG_BRCT_BRCA1_1 | 259 | 263 | PF00533 | 0.498 |
LIG_BRCT_BRCA1_2 | 259 | 265 | PF00533 | 0.396 |
LIG_deltaCOP1_diTrp_1 | 110 | 115 | PF00928 | 0.406 |
LIG_EH1_1 | 43 | 51 | PF00400 | 0.360 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.547 |
LIG_FHA_1 | 237 | 243 | PF00498 | 0.434 |
LIG_FHA_1 | 308 | 314 | PF00498 | 0.566 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.489 |
LIG_FHA_2 | 202 | 208 | PF00498 | 0.378 |
LIG_FHA_2 | 56 | 62 | PF00498 | 0.360 |
LIG_FHA_2 | 63 | 69 | PF00498 | 0.441 |
LIG_Integrin_RGD_1 | 98 | 100 | PF01839 | 0.458 |
LIG_LIR_Apic_2 | 207 | 211 | PF02991 | 0.368 |
LIG_LIR_Gen_1 | 101 | 112 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 101 | 107 | PF02991 | 0.357 |
LIG_PCNA_yPIPBox_3 | 36 | 50 | PF02747 | 0.392 |
LIG_SH2_CRK | 104 | 108 | PF00017 | 0.335 |
LIG_SH2_STAT3 | 40 | 43 | PF00017 | 0.377 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.578 |
LIG_SH2_STAT5 | 295 | 298 | PF00017 | 0.498 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.374 |
LIG_SH3_3 | 264 | 270 | PF00018 | 0.485 |
LIG_TYR_ITIM | 102 | 107 | PF00017 | 0.358 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.634 |
MOD_CK1_1 | 16 | 22 | PF00069 | 0.546 |
MOD_CK1_1 | 253 | 259 | PF00069 | 0.461 |
MOD_CK2_1 | 16 | 22 | PF00069 | 0.564 |
MOD_CK2_1 | 268 | 274 | PF00069 | 0.529 |
MOD_CK2_1 | 55 | 61 | PF00069 | 0.350 |
MOD_CK2_1 | 62 | 68 | PF00069 | 0.435 |
MOD_Cter_Amidation | 316 | 319 | PF01082 | 0.385 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.614 |
MOD_GlcNHglycan | 149 | 153 | PF01048 | 0.750 |
MOD_GlcNHglycan | 259 | 262 | PF01048 | 0.550 |
MOD_GlcNHglycan | 291 | 294 | PF01048 | 0.428 |
MOD_GSK3_1 | 246 | 253 | PF00069 | 0.406 |
MOD_GSK3_1 | 257 | 264 | PF00069 | 0.345 |
MOD_GSK3_1 | 291 | 298 | PF00069 | 0.443 |
MOD_N-GLC_1 | 257 | 262 | PF02516 | 0.628 |
MOD_N-GLC_1 | 27 | 32 | PF02516 | 0.633 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.529 |
MOD_NEK2_2 | 275 | 280 | PF00069 | 0.403 |
MOD_Plk_1 | 134 | 140 | PF00069 | 0.486 |
MOD_Plk_1 | 246 | 252 | PF00069 | 0.414 |
MOD_Plk_4 | 16 | 22 | PF00069 | 0.555 |
MOD_Plk_4 | 237 | 243 | PF00069 | 0.412 |
MOD_Plk_4 | 291 | 297 | PF00069 | 0.445 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.410 |
MOD_ProDKin_1 | 207 | 213 | PF00069 | 0.297 |
MOD_ProDKin_1 | 250 | 256 | PF00069 | 0.433 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.411 |
MOD_SUMO_rev_2 | 74 | 81 | PF00179 | 0.405 |
TRG_DiLeu_BaEn_4 | 68 | 74 | PF01217 | 0.483 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.337 |
TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.284 |
TRG_ER_diArg_1 | 106 | 109 | PF00400 | 0.346 |
TRG_ER_diArg_1 | 318 | 320 | PF00400 | 0.525 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0T3 | Leptomonas seymouri | 69% | 76% |
A0A0S4JP39 | Bodo saltans | 41% | 87% |
A0A1X0NTU5 | Trypanosomatidae | 44% | 80% |
A0A3R7RM36 | Trypanosoma rangeli | 50% | 86% |
A0A3S7WZT0 | Leishmania donovani | 88% | 100% |
A4I215 | Leishmania infantum | 88% | 100% |
C9ZRZ4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 89% |
E9AY63 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4Q9A9 | Leishmania major | 86% | 100% |
V5B9C8 | Trypanosoma cruzi | 54% | 85% |